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The largest measles outbreak in Berlin since 2001 
occurred from October 2014 to August 2015. Overall, 
1,344 cases were ascertained, 86% (with available 
information) unvaccinated, including 146 (12%) asylum 
seekers. Median age was 17 years (interquartile range: 
4–29 years), 26% were hospitalised and a 1-year-
old child died. Measles virus genotyping uniformly 
revealed the variant ‘D8-Rostov-Don’ and descend-
ants. The virus was likely introduced by and ini-
tially spread among asylum seekers before affecting 
Berlin’s resident population. Among Berlin residents, 
the highest incidence was in children aged < 2 years, 
yet most cases (52%) were adults. Post-exposure vac-
cinations in homes for asylum seekers, not always 
conducted, occurred later (median: 7.5 days) than the 
recommended 72 hours after onset of the first case 
and reached only half of potential contacts. Asylum 
seekers should not only have non-discriminatory, 
equitable access to vaccination, they also need to be 
offered measles vaccination in a timely fashion, i.e. 
immediately upon arrival in the receiving country. 
Supplementary immunisation activities targeting the 
resident population, particularly adults, are urgently 
needed in Berlin.
Introduction
Measles is a highly communicable viral disease caus-
ing substantial morbidity and mortality globally, mostly 
in low-income countries [1]. Vaccination can safely and 
effectively prevent measles disease and measles virus 
(MV)-induced immunosuppression, thereby also pre-
venting all-cause secondary infectious diseases [2]. The 
World Health Organization (WHO) has targeted mea-
sles and rubella for Regional elimination, and Germany 
has committed to this goal [3]. The key strategy for 
elimination is to achieve and sustain a population cov-
erage of ≥ 95% with two doses of a MV-containing vac-
cine [4,5]. Thus far, elimination has only been reached 
in the Americas [6,7]. The WHO European Region failed 
to achieve the target date for elimination in 2015 [8].
In Germany, immunisation is voluntary and the German 
Standing Committee on Vaccination (STIKO) recom-
mends routine administration of two doses of measles 
vaccine, at 11–14 and 15–23 months of age [9]. Although 
vaccine coverage for measles has increased substan-
tially in children at school entry (5- to 6-year-olds) in 
the last decade, it is still below the 95% target (93% 
in Germany for two doses of measles in 2014; 92% in 
Berlin) [10]. Since 2010, STIKO has additionally recom-
mended measles vaccination for adults born after 1970 
with incomplete or unknown vaccination status [11].
The European Union has recently experienced a very 
large influx of asylum seekers with more than 600,000 
and 1.3 million registered first-time applicants in 2014 
and 2015, respectively [12]; Germany had the largest 
number of applicants. In Berlin, a city with 3.5 mil-
lion inhabitants [13], 12,079 asylum seekers (12% from 
Bosnia and Herzegovina) were registered in 2014. This 
number more than tripled in 2015 (n = 44,615), with a 
steep increase in the second half of the year. Refugees 
and asylum seekers (both hereafter referred to as ‘asy-
lum seekers’) should have non-discriminatory, equita-
ble access to healthcare services, including vaccines, 
irrespective of their legal status [14-17]. Their right to 
receive vaccinations in Germany is legally anchored 
in the Asylum Seekers’ Benefit Act [18]. Asylum seek-
ers are accommodated in initial reception centres or 
collective accommodation centres (both hereafter 
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referred to as ‘asylum seeker homes’) upon arrival in 
Germany. The national recommendation for post-expo-
sure intervention in any community home, including 
asylum seeker homes, is to vaccinate all persons older 
than 9 months of age within 72 h after contact with a 
measles case [11].
Measles has been notifiable in Germany since 2001. 
From 2004 to 2013, the annual incidence per million 
population ranged from 1.5 to 28 without a discernible 
secular downward trend. During that time, the annual 
measles incidence was highest in Berlin, driven, in 
part, by a large outbreak with almost 500 reported 
cases in 2013. In October 2014, measles cases started 
to accumulate again in Berlin. Initially, most cases 
were in asylum seekers. We enhanced epidemiological 
surveillance of measles, evaluated post-exposure vac-
cination in homes for asylum seekers, and performed 
molecular surveillance of MV circulation. This report 
describes the epidemiological and molecular charac-




In Germany, clinical suspicion or diagnosis of mea-
sles, measles-related death and laboratory detection 
of measles infection are notifiable to the Local Public 
Health Authority (LPHA). The surveillance case defini-
tion requires that the patient have fever, maculopapu-
lar rash and one of the following: cough, coryza, Koplik 
spots or conjunctivitis, or an epidemiological link to a 
person with laboratory-confirmed measles infection. 
Laboratory confirmation was defined as detecting MV 
nucleic acid by PCR, or MV-specific IgM antibodies or a 
significant increase in anti-MV IgG. Cases were trans-
mitted to the State Office for Health and Social Affairs 
(SOHSA) and from there to the federal level public 
health institute.
Additional case information
We enhanced epidemiological surveillance of measles 
cases by requesting that LPHAs systematically collect 
additional information, including residency status (asy-
lum seeker (Y/N)), nationality, whereabouts in the two 
weeks before symptom onset and duration of stay in 
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Germany. Information was recorded in a specifically 
designed Excel sheet and sent to SOHSA.
Molecular data on MV
The National Reference Centre for Measles, Mumps, 
Rubella (NRC MMR) at the Robert Koch Institute, Berlin, 
determined the MV genotype in all clinical samples 
confirmed by detection of viral RNA that were collected 
in Berlin during the outbreak period. The ‘distinct 
sequence identifier’ representing each MV sequence 
variant was determined and compared using the global 
WHO Measles Nucleotide Surveillance (MeaNS) data-
base [19]. The phylogenetic tree was constructed using 
the neighbour-joining algorithm and the p-distance 
method as implemented in MEGA 7 [20].
For measles cases, we merged information from the 
notification database with additional case information 
and molecular data on MV by using the case identifier 
of the notification system or by date of onset, age, and 
sex (for molecular data from the NRC MMR).
Epidemiological investigation
We defined an outbreak case as illness in a person 
notified with measles in Berlin from 6 October 2014 
(week 41) until 30 August 2015 (week 35), if the illness 
fulfilled the surveillance case definition and was not 
imported (except for the index patient), and the isolate, 
if genotyped, belonged to genotype D8. A case was 
considered to be imported if the patient was abroad 
during the 7 to 18 days before symptom onset.
We conducted a descriptive analysis of case charac-
teristics by calculating frequencies and proportions or 
median values and interquartile ranges (IQR) as appro-
priate. Attack rates per million population, by age 
group and district, were computed for Berlin resident 
cases using 2013 population data from the Statistical 
Office for Berlin-Brandenburg.
Evaluation of post-exposure vaccinations in 
asylum seeker homes
We evaluated timeliness and completeness of post-
exposure vaccinations in asylum seeker homes 
between October 2014 and February 2015. Date of 
symptom onset and notification of the first case was 
extracted from the notification system, details on 
the intervention (e.g. date, number of (eligible) asy-
lum seekers vaccinated/registered) were collected 
by LPHAs and collated by the SOHSA. We computed 
median values and IQR of time intervals characterising 
the timeliness of the intervention. Completeness was 
assessed only in post-exposure vaccinations targeting 
all asylum seekers, which excluded homes that had 
closed living units and interventions restricted to spe-
cific vulnerable subgroups, e.g. children or husbands 
of pregnant women. It was computed as the number of 
vaccinated asylum seekers divided by the total number 
of (eligible) registered asylum seekers. Persons older 
than 9 months of age who were not pregnant and had 
no clinical signs compatible with measles and no writ-
ten documentation of two measles vaccinations were 
eligible.
Molecular investigation
Suspected measles cases were confirmed in private or 
hospital laboratories or in the NRC MMR using tests for 
detection of anti-MV IgM in serum. Alternatively, MV 
RNA was detected in throat swabs, oral fluid or urine 
by an accredited PCR test conducted in the NRC MMR. 
Detected MV was genotyped by sequencing the 450 
nucleotides (nt) coding for the C-terminal 150 amino 
acids of the nucleoprotein and phylogenetic analysis 
as recommended by the WHO [21]. Representative MV 
sequence data were submitted to the MeaNS database 
and to GenBank [19].
Results
Description of the outbreak
Of 1,359 cases notified during the outbreak period, 15 
were considered unrelated to the outbreak; six because 
of genotypes other than D8 and nine because infection 
was considered imported, among them three asylum 
seekers (all from Bosnia and Herzegovina). Thus, 1,344 
outbreak cases were ascertained, of which 943 (70%) 
were laboratory-confirmed (Table).
Median age of case patients was 17 years (IQR: 4–29 
years), 737 (55%) were male, 345 (26%) were hospital-
ised and a 1-year-old child died of measles. In almost 
two thirds of cases (64%, n = 864), no link to another 
measles case was recorded by the LPHAs. Of those 
with available information (n = 1,258), 86% (n = 1,086) 
were not vaccinated against measles, 101 (8%) were 
vaccinated once, 42 (3%) twice and one case three 
times (0.2%) before onset of illness (for 28 (2%) the 
number of vaccinations was not recorded).
The index case was a 5-year-old child who travelled 
with their family from Bosnia and Herzegovina by bus 
Figure 2
Attack rates per 1,000,000 by age group among the 
resident population in a large outbreak of measles in 
Berlin, October 2014–August 2015
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to Berlin (a ca 24  h drive) in early October 2014. The 
child had fever but no rash upon arrival. In the follow-
ing months, cases occurred predominantly among asy-
lum seekers (Figure 1).
During the outbreak, 146 (11%) cases occurred in asy-
lum seekers (Table), most of them in children (median 
age: 5 years, IQR 2–18 years). Overall, 69 (47%) came 
from Bosnia and Herzegovina (in 2014: 41/65 cases, 
63%), 41 (28%) from Serbia, eight (6%) from Syria, 
the remaining 20% came from 14 different countries. 
Measles cases occurred in 35 homes for asylum seek-
ers, located in all Berlin districts, with a median of two 
cases per asylum seeker home (IQR: 1–5).
By year’s end, cases started to accumulate in the Berlin 
resident population, with a peak in March 2015 (Figure 
1). Cases among Berlin residents (n = 1,101) occurred 
in all districts, but the attack rate varied across the 
12 districts of Berlin by a factor of almost 3.5 (high-
est in Neukölln: 546/1,000,000 population, lowest in 
Steglitz-Zehlendorf: 160/1,000,000 population (city-
wide incidence: 309/1,000,000 population). Of the 
Berlin resident cases, almost one third (n = 349, 32%) 
were linked to other cases in 132 clusters (median 
number of cases: 2, IQR: 2–3), mostly to household 
members (253 cases in 106 clusters), meaning that 
no long transmission chains or sub-outbreaks were 
observed. Attack rate was highest among < 1 year olds 
(3,334/1,000,000, Figure 2) followed by 1 year-olds 
(2,538/1,000,000, which together accounted for 18% 
of Berlin’s resident cases. The majority of cases were 
in adults (n = 571, 52%), most of whom (498/571, 87%) 
were born after 1970.
Evaluation of post-exposure vaccinations in 
asylum seeker homes
In the study period, cases were ascertained in 32 asy-
lum seeker homes. Case-patients’ median age in clus-
ters in asylum seeker homes was 4 years (IQR: 1–18.5 
years). Of 32 asylum seeker homes, we received no 
detailed information for seven homes, and in a further 
seven homes no post-exposure intervention was per-
formed for different reasons (e.g. lack of resources). In 
the remaining 18 homes, post-exposure vaccinations 
were conducted with a median time interval from symp-
tom onset of the first case to vaccination of 7.5 days 
(IQR: 6–10 days); in three homes vaccination occurred 
within the recommended 72  h after detection of mea-
sles with no further cases notified during the follow-
ing 18 days. In the remaining 15 homes, 16 cases were 
notified during this time period. Median time interval 
between (i) symptom onset of the first case and notifi-
cation and (ii) notification and post-exposure vaccina-
tion was 4 days (IQR: 3–8 days) and 2 days (IQR: 0–6 
days), respectively.
In the eight asylum seeker homes where vaccination 
was offered to all inhabitants and denominator data 
were available, 1,133/2,390 (47%) were reached. In five 
of these homes, eligibility criteria for vaccination were 
also recorded; there, 706/1,344 (53%) were reached.
Molecular investigation
During the outbreak period, the NRC received samples 
from 587 suspected cases. MV genome was detected in 
samples from 415 laboratory-confirmed cases and the 
MV genotype was determined for 359 cases of which 
354 showed a wild-type virus. Of the 351 cases associ-
ated with genotype D8, 306 showed the predominant 
sequence variant Named Strain MVs/Rostov on Don.
RUS/47.13/2, hereafter referred to as ‘D8-Rostov-Don’. 
This variant was detected in Berlin during the entire 
outbreak period and had previously been found during 
a large outbreak in Bosnia and Herzegovina (February 
2014 to April 2015). Forty-five cases had variants 
Figure 3
Phylogenetic relationship between the measles virus 
sequence variants detected in a large outbreak of measles 
in Berlin, August 2014–October 2015 (n = 351), a large 
outbreak in Bosnia and Herzegovina (2014–2015) and the 
World Health Organization Reference and Named Strains 







































The World Health Organization name, the GenBank accession 
number (if available) and the ‘distinct sequence identifier’ used 
in MeaNS are given for each sequence variant. The phylogenetic 
analysis is based on the 450-nt sequence encoding the C-terminus 
of the measles virus N protein. The tree was constructed using 
the Neighbour-Joining algorithm and the p-distance method as 
implemented in MEGA7 [20]. Bootstrap values (1,000 replicates) 
are shown next to the branches. The scale bar indicates a deviation 
of 5 nt per 1,000 nt sequence.
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deviating in the 450 nt region by 1–2 nt from D8-Rostov-
Don (10 variants, Figure 3) [22]. One variant detected in 
Berlin from December 2014 to May 2015 (MVs/Berlin.
DEU/01.15) was also found in the course of the afore-
mentioned outbreak (MVs/Lukavac.BIH/05.15) [22].
We were able to match 322 laboratory-confirmed cases 
with MV genotype D8 to notified outbreak cases (254 
Berlin residents and 46 asylum seekers and in 22 with 
unknown residency status), of which 282 (88%) had 
the variant D8-Rostov-Don and 40 (12%) had a 1–2 
nt deviating variant (Figure 4), 11 asylum seekers, 28 
Berlin residents, one case with unknown residency 
status. None of these cases had a travel history during 
their period of infection. Of these 40 cases, 24 shared 
an identical variant (MVs/Lukavac.BIH/05.15). The first 
of these cases had a symptom onset on 20 December 
2014 and the last on 21 May 2015.
Discussion
In this large outbreak, MV was likely introduced by and 
initially spread among asylum seekers before affect-
ing the resident population of Berlin, which ultimately 
accounted for the vast majority of cases. Among Berlin’s 
resident population, all age groups eligible for vaccina-
tion were affected, with the highest attack rate in chil-
dren under 2 years of age. More than half of the cases 
were in adults, most of whom were born after 1970, the 
age group for which STIKO recommends measles vacci-
nation if vaccination history is incomplete or unknown. 
Interventions of LPHAs in homes for asylum seekers 
were mostly outside the recommended 72 h time win-
dow, reached only half of the potential contacts and 
apparently did not halt the outbreak. Continuous geno-
typing throughout the outbreak period demonstrated 
almost endemic (i.e.  ≥ 12 months) transmission of the 
predominant variant D8-Rostov–Don in Berlin.
Several lines of evidence indicate that measles was 
introduced by and initially spread among asylum 
seekers: firstly, the index case occurred in an asy-
lum seeker who had symptoms upon arrival in Berlin, 
after travelling from Bosnia and Herzegovina where a 
large measles outbreak was ongoing at that time [22]. 
Subsequent cases occurred predominantly among asy-
lum seekers (often from Bosnia and Herzegovina) that 
Figure 4
Measles virus sequence variants (given by the ‘distinct sequence identifier’) by reporting week of cases in a large outbreak in 

































acquired infection in Berlin. Secondly, genotyping data 
indicate sequence identity of MV isolated from the 
index case, the large majority of the following cases 
in Berlin, and cases of the concurrent outbreak in 
Bosnia and Herzegovina. Thirdly, despite of continuous 
monitoring of circulating MV variants, the main variant 
D8-Rostov-Don and closely related variants had never 
been found in Berlin before.
Population immunity in Berlin was too low to prevent 
city-wide measles spread across all age groups, equat-
ing to insufficient vaccine coverage. School-entry 
examinations document that coverage with two doses 
of a MV-containing vaccine has been consistently 
below 95% in Berlin, although there has been a strong 
increase over the past 15 years (from 21% in 1998–2001 
to 92% in 2014) [10,23]. Age-dependent differences in 
vaccine coverage were observed in a national popula-
tion survey from 2008 to 2011; coverage (1 dose) was 
lower in older age groups (80% in 18–29 year olds; 47% 
in 30–39 year olds) [24]. Taken together, population 
immunity likely decreases in Germany with increasing 
age, until age groups born before 1970.
The majority of cases were in adults. Of note, there is a 
clear shift towards adult measles cases in German noti-
fication data (from 11% in 2003 to 43% in 2013) [25], in 
the absence of a noticeable downward trend in measles 
notification rates over the past 10 years in Germany. 
Furthermore, under-reporting of measles in Germany 
is highest in adults [26]. Consequently, their involve-
ment in this outbreak (and in measles epidemiology in 
Germany in general) can be assumed to be dispropor-
tionately underestimated and the difference in attack 
rates between adults and children in this outbreak is 
likely offset, at least partially. Interestingly, standard 
inquiries of cases in this outbreak by LPHAs revealed 
that adults tended to be ignorant of their vaccination 
status rather than sceptical of vaccines, suggesting 
they could be successfully targeted in catch-up cam-
paigns (not yet conducted in Berlin or elsewhere in 
Germany) [27].
Post-exposure vaccination by LPHAs to prevent onward 
transmission in homes for asylum seekers were not 
always conducted and, where conducted, reached 
only half of the potential contacts. Additionally, most 
(83%) vaccination measures occurred after the recom-
mended 72 h window, mainly because LPHAs were not 
notified in a timely fashion (vaccinating after 72 h may 
still be useful, e.g. to prevent tertiary cases). We did 
not systematically assess the reasons for delayed case 
notification. Anecdotally, not all cases sought medical 
attention immediately and sometimes the first noti-
fied case was initially misdiagnosed with a disease 
other than measles. Furthermore, the large number 
of asylum seekers in some homes often exceeded the 
response capacity of the LPHAs. Taken together, timely 
vaccination of all contacts proved challenging in these 
settings where LPHA often became aware of measles 
too late, potential contacts were often difficult to reach 
and large in number, and language barriers compli-
cated intervention logistics. Of note, clusters occurred 
in many homes for asylum seekers (mostly involving 
children), but were small in size (median of two cases). 
This indicates a fairly high vaccination coverage among 
inhabitants as has been shown for migrating popu-
lations in other settings, an effect of post-exposure 
vaccinations, or both [28,29]. Targeting, or at least 
prioritising, vulnerable groups (e.g. children) in post-
exposure vaccinations in (mass) asylum seeker homes 
should be considered, particularly in crisis situations.
It remains unclear why the outbreak became so large 
and long-lasting. Frequent introduction of the outbreak 
virus by different asylum seekers may seem an obvi-
ous explanation, but the limited available epidemio-
logical and molecular information lends little support 
Table
Case characteristics in a large outbreak of measles in Berlin, October 2014–August 2015 (n = 1,344)
Characteristics
Berlin resident Asylum seeker      Unknown      Total
n % n % n % n %
Number of cases 1,101 100 146 100 97 100 1,344 100
Male 612 55.6 76 52.0 49 50.5 737 54.8
Laboratory-confirmed 777 70.6 99 67.8 67 69.1 943 70.2
In clusters 349 31.7 107 73.3 24 24.7 480 35.7
Unvaccinated a 888 85.2 127 94.1 71 87.6 1,086 86.3
Hospitalised b 265 24.1 35 24.0 45 46.9 345 25.7
Death 1 0.1 0 0 0 0 1 0.1
Median IQR Median IQR Median IQR Median IQR 
Age (years) 18 5–30 5 2–18 21 9–29 17 4–29
IQR: interquartile range.
a Information was available for 1,258 cases on vaccination status; 1,042 Berlin residents, 135 asylum seekers, 81 unknown.
b Information was available for 1,342 on hospitalisation status; 1,100 Berlin residents, 146 asylum-seekers, 96 unknown.
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to this hypothesis. Only three measles cases among 
asylum seekers (all from Bosnia and Herzegovina) 
were considered imported. Yet, under-ascertainment 
of measles cases is likely, particularly at the start of 
the outbreak (e.g. there is a gap of > 3 weeks in onset 
dates between the index and subsequent cases). The 
identification of various outbreak variants is not nec-
essarily indicative of imported MV. All variants were 
closely related to the main outbreak variant D8-Rostov-
Don. Most were detected only once or over a short 
period, and their occurrence scattered around the 
(virus-number) peak of the outbreak, which is compat-
ible with random mutations of the virus. Furthermore, 
detection of a variant probably descending from the 
outbreak main variant has previously been observed in 
a large outbreak, in which multiple importations were 
deemed unlikely [30]. In keeping with that pattern, 
none of the (matched) cases infected with an outbreak 
variant deviating from the main variant were imported. 
However, the predominant and the second most variant 
identified in Berlin were also detected in the outbreak 
in Bosnia and Herzegovina, indicating at least two viro-
logical links to the parallel outbreak. Notwithstanding, 
our molecular analysis was restricted to 450 nt of the 
MV N gene, and therefore does not allow the monitor-
ing of sequence variation in other regions of the viral 
genome. Establishing whole genome sequencing in 
outbreak situations across Europe might provide more 
detailed information. More important, however, is a 
continuous monitoring of virus variants during the 
whole outbreak period, especially when considering 
increasing population movement in recent years.
Enhancing the surveillance of notified measles cases, 
including routinely collecting information on residency 
status, and MV genotyping, were pivotal in understand-
ing the epidemiology of this outbreak. Since October 
2015, residency status and accompanying information 
have been routinely collected on all notifiable diseases 
in Germany. Although the data need to be interpreted 
with caution, they indicate that most notified infectious 
diseases in asylum seekers are vaccine-preventable 
(predominantly varicella zoster infections), and most 
are acquired within Germany (data not shown). This 
underlines the vulnerability of this group for vaccine-
preventable diseases.
No city-wide system for offering vaccinations to asylum 
seekers was in place during the outbreak period. Since 
September 2015, Berlin has offered immunisation with 
MV- (and polio-) containing vaccines, as recommended 
by WHO, the European Centre for Disease Prevention 
and Control and STIKO, to all asylum seekers in Berlin 
[31,32]. Coupled with a brief medical examination, 
this has become an integral part of the asylum seek-
ers’ registration process since March 2016 in Berlin. 
Notwithstanding, there remains a continued risk of 
importation of MV as many residents travel and many 
travellers arrive. In 2014, 12.4 million people visited 
Berlin, of which 4.8 million came from abroad (one fifth 
of all foreign visitors to Germany) [33]. In conjunction 
with insufficient population immunity, eliminating mea-
sles in Berlin is likely to remain a distant prospect in 
the absence of supplementary immunisation activities.
Conclusion
This outbreak exemplifies why, in addition to ethical 
and legal grounds, asylum seekers should be timely 
offered vaccination against measles: to protect them. 
In addition, catch-up campaigns to close immunisa-
tion gaps, particularly in adults, are urgently needed in 
Berlin’s resident population. Surveillance of infectious 
diseases should routinely collect information on resi-
dency status to be able to assess and quickly respond 
to infectious disease risks in asylum seekers. MV gen-
otyping throughout the outbreak period demonstrated 
continuous circulation of variant D8-Rostov-Don for 
almost 11 months in Berlin.
Acknowledgements
We are indebted to the 12 local public health authorities in 
Berlin for their diligent and committed work and collabora-
tion in this outbreak.





DW contributed to data collection, data analysis, data inter-
pretation and drafting the manuscript.
AH contributed to literature search, data collection, data 
analysis, data interpretation, creating graphics and drafting 
the manuscript.
AM contributed to molecular-biological investigation. SS 
contributed to molecular-biological investigation and creat-
ing graphics.
DS contributed to data collection and data interpretation.
References
1. Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders 
MN, Strebel PM,  et al.  Progress toward regional measles 
elimination - worldwide, 2000-2014. MMWR Morb Mortal Wkly 
Rep. 2015;64(44):1246-51. DOI: 10.15585/mmwr.6444a4 PMID: 
26562349
2. Mina MJ, Metcalf CJE, de Swart RL, Osterhaus ADME, Grenfell 
BT. Long-term measles-induced immunomodulation increases 
overall childhood infectious disease mortality.Science. 
2015;348(6235):694-9. DOI: 10.1126/science.aaa3662 PMID: 
25954009
3. Bundesministerium für Gesundheit. [Federal Ministry of 
Health]. Nationaler Aktionsplan 2015-2020 zur Elimination der 
Masern und Röteln in Deutschland: Hintergründe, Ziele und 
Strategien. [National action plan 2015-2020 for the elimination 
of measles and rubella in Germany: Background, goals and 
strategies]. Berlin: Federal Ministry of Health; [Accessed 13 Feb 
2017]. German. Available from: https://www.gmkonline.de/
documents/Aktionsplan_Masern_Roeteln_2.pdf
4. World Health Organization Regional Office for Europe (WHO 
Europe). Eliminating measles and rubella and preventing 
8 www.eurosurveillance.org
congenital rubella infection: WHO European Region strategic 
plan 2005-2010. Copenhagen: WHO Europe; 2005. [Accessed 
9 Feb 2017]. Available from: http://www.euro.who.int/__data/
assets/pdf_file/0008/79028/E87772.pdf
5. World Health Organization Regional Office for Europe (WHO 
Europe). Eliminating measles and rubella: Framework for 
the verification process in the WHO European Region. 





6. Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, 
Wallace GS. Measles - United States, January 4-April 2, 2015.
MMWR Morb Mortal Wkly Rep. 2015;64(14):373-6.PMID: 
25879894
7. Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn 
AP, Armstrong GL,  et al.  Elimination of endemic measles, 
rubella, and congenital rubella syndrome from the 
Western hemisphere: the US experience. JAMA Pediatr. 
2014;168(2):148-55. DOI: 10.1001/jamapediatrics.2013.4342 
PMID: 24311021
8. World Health Organization (WHO). Global measles and 
rubella strategic plan: 2012-2020. Geneva: WHO; [Accessed 
9 Feb 2017]. Available from: http://apps.who.int/iris/
bitstream/10665/44855/1/9789241503396_eng.pdf.
9. Robert Koch-Institut (RKI). Empfehlungen der Ständigen 
Impfkommission (STIKO) am RKI. [Recommendations of 
the German Standing Committee on Vaccination (STIKO) at 
the RKI]. Epidemiologisches Bulletin. Berlin: RKI; 29 Aug 
2016. German. Available from: https://www.rki.de/DE/
Content/Infekt/EpidBull/Archiv/2016/Ausgaben/34_16.
pdf?__blob=publicationFile
10. Robert Koch-Institut (RKI). Impfquoten bei der 
Schuleingangsuntersuchung in Deutschland 2014. [Vaccine 
coverage at school entry examination in Germany in 2014]. 
Berlin: RKI; 25 Apr 2016. German. Available from: https://
www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2016/
Ausgaben/16_16.pdf?__blob=publicationFile
11. Robert Koch-Institut (RKI). Mitteilung der Ständigen 
Impfkommission (STIKO) am Robert Koch-Institut (RKI). 
[Information of the German Standing Committee on Vaccination 
(STIKO) at the RKI]. Berlin: RKI; 16 Aug 2010. German. Available 
from: https://www.rki.de/DE/Content/Infekt/EpidBull/
Archiv/2010/Ausgaben/32_10.pdf?__blob=publicationFile.
12. Eurostat. Database: Asylum and managed migration (migr). 
Luxembourg: Eurostat; [Accessed 1 Aug 2017]. Available from: 
http://ec.europa.eu/eurostat/data/database?node_code=migr
13. Amt für Statistik Berlin-Brandenburg. [Office for Statistics 
Berlin-Brandenburg]. Statistiken. [Statistics]. Berlin: Office for 
Statistics Berlin Brandenburg; [Accessed 13 Feb 2017]. German. 
Available from: https://www.statistik-berlin-brandenburg.de/
Statistiken/inhalt-statistiken.asp
14. World Health Organization Regional Office for Europe (WHO 
Europe). Health2020: A European policy framework and 
strategy for the 21st century. Copenhagen: WHO Europe; 2013. 
[Accessed 9 Feb 2017]. Available from: http://www.euro.who.
int/__data/assets/pdf_file/0011/199532/Health2020-Long.
pdf?ua=1
15. Weis P. The Convention Relating to the Status of Stateless 
Persons.Int Comp Law Q. 1961;10(10(2)):255-64. DOI: 10.1093/
iclqaj/10.2.255
16. Declaration of Alma-Ata. Lancet. 1979;1(8109):217-8. PMID: 
84242
17. World Health Organization (WHO). Sixty-First World Health 
Assembly. Geneva, 19-24 May 2008. Geneva: WHO; [Accessed 
9 Feb 2017]. Available from: http://apps.who.int/gb/ebwha/
pdf_files/WHA61-REC1/A61_REC1-en.pdf
18. Federal Ministry of Justice. Asylbewerberleistungsgesetz. 
[Asylum Seekers’ Benefit Act]. Bonn: Bundesgesetzblatt 
(BGBI). I S. 2541. 17 Jul 2017. [Accessed 31 Jul 2017]. Available 
from: http://www.gesetze-im-internet.de/bundesrecht/
asylblg/gesamt.pdf
19. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller 
CP,  et al.  Global distribution of measles genotypes and 
measles molecular epidemiology. J Infect Dis. 2011;204(Suppl 
1):S514-23. DOI: 10.1093/infdis/jir118 PMID: 21666208
20. Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary 
Genetics Analysis Version 7.0 for Bigger Datasets.Mol Biol 
Evol. 2016;33(7):1870-4. DOI: 10.1093/molbev/msw054 PMID: 
27004904
21. World Health Organization (WHO). Measles virus nomenclature 
update: 2012.Wkly Epidemiol Rec. 2012;87(9):73-81.PMID: 
22462199
22. Salimović-Bešić I, Šeremet M, Hübschen JM, Hukić M, Tihić N, 
Ahmetagić S,  et al.  Epidemiologic and laboratory surveillance 
of the measles outbreak in the Federation of Bosnia and 
Herzegovina, February 2014-April 2015. Clin Microbiol Infect. 
2016;22(6):563.e1-7. DOI: 10.1016/j.cmi.2016.02.005 PMID: 
26928202
23. Robert Koch-Institut (RKI). Impfraten deutscher Kinder bei der 
Schuleingangsuntersuchung im Jahr 2002. [Vaccine coverage 
of German children at school entry examination in the year 
2002]. Epidemiologisches Bulletin. Berlin: RKI; 30 Apr 2003. 
German. Available from: http://edoc.rki.de/documents/rki_fv/
rePoSwYQt9oyc/PDF/24xN0iiVGsOc.pdf
24. Poethko-Müller C, Schmitz R. Impfstatus von Erwachsenen 
in Deutschland: Ergebnisse der Studie zur Gesundheit 
Erwachsener in Deutschland (DEGS1). [Vaccination 
coverage in German adults: results of the German 
Health Interview and Examination Survey for Adults 
(DEGS1)].Bundesgesundheitsblatt Gesundheitsforschung 
Gesundheitsschutz. 2013;56(5-6):845-57. DOI: 10.1007/s00103-
013-1693-6 PMID: 23703506
25. Robert Koch-Institut (RKI). SurvStat@RKI 2.0. Berlin: RKI; 
[Accessed 9 Feb 2017]. Available from: https://survstat.rki.de/
Content/Query/Create.aspx
26. Takla A, Wichmann O, Rieck T, Matysiak-Klose D. Measles 
incidence and reporting trends in Germany, 2007-2011.
Bull World Health Organ. 2014;92(10):742-9. DOI: 10.2471/
BLT.13.135145 PMID: 25378728
27. Hoffmann A, Sagebiel D, Hentschel K, Werber D. Large measles 
outbreak in Berlin 2014/2015 - Many cases not opposed to 
vaccination, yet unvaccinated (reference number 3048). In: 
European Scientific Conference on Applied Infectious Disease 
Epidemiology (ESCAIDE). Abstract Book; 1-13 Nov 2015; 
Stockholm, Sweden. Stockholm: ESCAIDE;2015. [Accessed 12 
Dec 2016]. p. 58. Available from: http://www.escaide.eu/sites/
escaide/files/documents/escaide-2015-abstract-book.pdf
28. Barnett ED, Christiansen D, Figueira M. Seroprevalence of 
measles, rubella, and varicella in refugees.Clin Infect Dis. 
2002;35(4):403-8. DOI: 10.1086/341772 PMID: 12145723
29. Greenaway C, Dongier P, Boivin J-F, Tapiero B, Miller M, 
Schwartzman K. Susceptibility to measles, mumps, and 
rubella in newly arrived adult immigrants and refugees.Ann 
Intern Med. 2007;146(1):20-4. DOI: 10.7326/0003-4819-146-1-
200701020-00005 PMID: 17200218
30. Mankertz A, Mihneva Z, Gold H, Baumgarte S, Baillot A, Helble 
R,  et al.  Spread of measles virus D4-Hamburg, Europe, 2008-
2011. Emerg Infect Dis. 2011;17(8):1396-401. DOI: 10.3201/
eid1708.101994 PMID: 21801615
31. World Health Organization Regional Office for Europe (WHO 
Europe). WHO-UNHCR-UNICEF joint technical guidance: general 
principles of vaccination of refugees, asylum-seekers and 
migrants in the WHO European Region. Copenhagen: WHO 







32. European Centre for Disease Prevention and Control (ECDC). 
Rapid Risk Assessment. Communicable disease risks 
associated with the movement of refugees in Europe during the 
winter season. Stockholm: ECDC; 10 Nov 2015. Available from: 
http://ecdc.europa.eu/en/publications/Publications/refugee-
migrant-health-in-european-winter-rapid-risk-assessment.pdf
33. Amt für Statistik Berlin-Brandenburg. [Office for Statistics 
Berlin-Brandenburg]. Tourismus Basisdaten. [Tourism. 
Basic data]. Berlin: Office for Statistics Berlin-Brandenburg; 




This is an open-access article distributed under the terms of 
the Creative Commons Attribution (CC BY 4.0) Licence. You 
may share and adapt the material, but must give appropriate 
credit to the source, provide a link to the licence, and indi-
cate if changes were made.
This article is copyright of the authors, 2017.
